Once tumors are coated by platelets, platelets inhibit NK cell-mediated antitumor activity through downregulating tumor cell NK2D expression by TGFβ and inducing pseudoexpression of immunomodulating molecules, such as MHC I and GITR (83–85). This evidence concerns the gene TGFB1 and neoplasm.